KCM Investment Advisors LLC Has $706,000 Stake in McKesson Co. (NYSE:MCK)

KCM Investment Advisors LLC reduced its position in shares of McKesson Co. (NYSE:MCK) by 12.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,238 shares of the company’s stock after selling 180 shares during the quarter. KCM Investment Advisors LLC’s holdings in McKesson were worth $706,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Resona Asset Management Co. Ltd. acquired a new position in McKesson during the fourth quarter valued at $29,898,000. Islay Capital Management LLC increased its holdings in shares of McKesson by 4,992.0% in the 4th quarter. Islay Capital Management LLC now owns 1,273 shares of the company’s stock valued at $725,000 after purchasing an additional 1,248 shares during the period. Lynwood Price Capital Management LP purchased a new stake in shares of McKesson in the fourth quarter worth approximately $7,181,000. First Western Trust Bank boosted its holdings in shares of McKesson by 2.0% during the fourth quarter. First Western Trust Bank now owns 931 shares of the company’s stock worth $531,000 after purchasing an additional 18 shares during the period. Finally, Smith Moore & CO. purchased a new position in McKesson during the fourth quarter valued at approximately $209,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Stock Performance

Shares of McKesson stock opened at $682.41 on Friday. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $728.32. The firm has a market cap of $85.52 billion, a P/E ratio of 31.25, a price-to-earnings-growth ratio of 1.29 and a beta of 0.49. The firm’s 50-day simple moving average is $633.37 and its 200-day simple moving average is $585.40.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, equities analysts forecast that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd were issued a dividend of $0.71 per share. The ex-dividend date was Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.42%. McKesson’s payout ratio is presently 13.00%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on MCK. Morgan Stanley increased their target price on shares of McKesson from $642.00 to $745.00 and gave the stock an “overweight” rating in a research report on Wednesday. Citigroup reduced their price target on McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Wells Fargo & Company increased their price objective on McKesson from $641.00 to $691.00 and gave the stock an “equal weight” rating in a report on Friday, March 14th. StockNews.com cut shares of McKesson from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Finally, Evercore ISI increased their price target on shares of McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a research note on Thursday, February 6th. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $661.00.

Insider Activity

In other McKesson news, EVP Leann B. Smith sold 188 shares of the business’s stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total value of $114,602.92. Following the transaction, the executive vice president now directly owns 1,051 shares in the company, valued at $640,679.09. The trade was a 15.17 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Brian S. Tyler sold 8,961 shares of the firm’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $600.66, for a total transaction of $5,382,514.26. Following the sale, the chief executive officer now directly owns 69,625 shares of the company’s stock, valued at approximately $41,820,952.50. The trade was a 11.40 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 18,110 shares of company stock worth $10,855,706. Corporate insiders own 0.11% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.